1. Home
  2. EVOK vs UBXG Comparison

EVOK vs UBXG Comparison

Compare EVOK & UBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • UBXG
  • Stock Information
  • Founded
  • EVOK 2007
  • UBXG 2018
  • Country
  • EVOK United States
  • UBXG China
  • Employees
  • EVOK N/A
  • UBXG N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • UBXG
  • Sector
  • EVOK Health Care
  • UBXG
  • Exchange
  • EVOK Nasdaq
  • UBXG Nasdaq
  • Market Cap
  • EVOK 7.0M
  • UBXG 6.1M
  • IPO Year
  • EVOK 2013
  • UBXG 2024
  • Fundamental
  • Price
  • EVOK $4.96
  • UBXG $3.36
  • Analyst Decision
  • EVOK
  • UBXG
  • Analyst Count
  • EVOK 0
  • UBXG 0
  • Target Price
  • EVOK N/A
  • UBXG N/A
  • AVG Volume (30 Days)
  • EVOK 38.4K
  • UBXG 344.0K
  • Earning Date
  • EVOK 11-07-2024
  • UBXG 12-31-2024
  • Dividend Yield
  • EVOK N/A
  • UBXG N/A
  • EPS Growth
  • EVOK N/A
  • UBXG N/A
  • EPS
  • EVOK N/A
  • UBXG N/A
  • Revenue
  • EVOK $8,617,036.00
  • UBXG $51,600,106.00
  • Revenue This Year
  • EVOK $97.35
  • UBXG N/A
  • Revenue Next Year
  • EVOK $99.52
  • UBXG N/A
  • P/E Ratio
  • EVOK N/A
  • UBXG N/A
  • Revenue Growth
  • EVOK 100.35
  • UBXG N/A
  • 52 Week Low
  • EVOK $3.54
  • UBXG $0.26
  • 52 Week High
  • EVOK $14.04
  • UBXG $35.44
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 54.79
  • UBXG N/A
  • Support Level
  • EVOK $4.33
  • UBXG N/A
  • Resistance Level
  • EVOK $5.75
  • UBXG N/A
  • Average True Range (ATR)
  • EVOK 0.39
  • UBXG 0.00
  • MACD
  • EVOK 0.13
  • UBXG 0.00
  • Stochastic Oscillator
  • EVOK 54.34
  • UBXG 0.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

Share on Social Networks: